
Nominations are now Open for the 2025 Health Research Foundation’s Medal of Honour
NOMINATE OUTSTANDING CONTRIBUTIONS TO HEALTH SCIENCES, POLICY, AND RESEARCH BY JULY 15, 2025 Ottawa, April 23 – The Health Research […]
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
NOMINATE OUTSTANDING CONTRIBUTIONS TO HEALTH SCIENCES, POLICY, AND RESEARCH BY JULY 15, 2025 Ottawa, April 23 – The Health Research […]
Ottawa, April 1, 2025 – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare […]
Ottawa, March 21, 2025 – With the imminent announcement of a federal election, Canadians have an opportunity to reflect on the […]
Industry Association Applauds Commitment to the Stratégie Québécoise des sciences de la vie (2025-2028) and to Pharmaceuticals in Hospital Settings […]
Ottawa, February 3, 2025 – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President […]
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
This article originally appeared in Saltwire newspapers across Atlantic Canada on July 11, 2024. Dr. P.J. Devereaux, co-chair of Accelerating Clinical Trials […]
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
Sign up to our newsletter to get our latest news and updates.
Browse by topic
Informative content to keep you up to date on the most pressing issues facing our industry.